TruthArchive.ai - Related Video Feed

Researchers examined tissues for spike and nucleocapsid proteins in a patient with COVID-19. Spike proteins are targeted by vaccines, while nucleocapsid proteins are not. In respiratory secretions, spike proteins were found, indicating the virus's presence. In the brain of a vaccinated patient who died, spike proteins were present, but nucleocapsid proteins were not. The absence of nucleocapsid proteins in the brain is puzzling.

Dr. Pretorius and a colleague discuss unusual clotting observed after COVID-19 vaccination, including embalmers reporting back pressure when introducing embalming fluid and the extraction of very long, congealed clots—six inches to several feet—as well as patients with long brachial clots. They note thousands of clotting reports in VAERS across all vaccine types, describing these clots as not normal. Some clots cause major emboli affecting circulation to the lungs, detected by scans and perfusion studies, while others are microclots with a branching pattern visible in imaging. A clinician also shared a photo of a clot with a complete branching pattern into medium and smaller vessels. Dr. Pretorius’ work is cited to explain the mechanism: spike protein can induce immediate clumping of proteins in platelet-poor plasma in the absence of platelets, a highly unusual clotting pathway not relying on the classical coagulation cascade. This is described as a proteinaceous, pseudo-amyloid–like clot. The spike protein is reported to circulate after vaccination, with studies in the Journal of Immunology showing spikes in circulation and exosomes up to four months after shots. Long-haul COVID data (Patterson’s study) reportedly shows S1 protein present in nonclassical monocytes in blood, suggesting persistence of spike protein, whether from infection or the vaccine, which can induce clotting pathways on its own. Dr. Pretorius discusses observations of upregulation of intercellular adhesion molecules (ICAMs) on leukocytes within clots, causing white blood cells to adhere in addition to fibrin, contributing to difficulty in dissolving these clots. Concerning treatment and detection, the speakers describe depletion of plasminogen, reducing the body’s ability to break down clots, and note that standard anticoagulants are less effective against these clots, which are described as amyloid-like and atypical. They emphasize that these are not the classical clotting pathways involving platelet activation and typical thrombin–fibrin cascades. They contrast this with expectations of standard clotting mechanisms and reference the unusual, non-classical pathway highlighted by Pretorius. The discussion also mentions the idea that spike protein in circulation can drive clotting without the usual platelet activation, and that some patients have continued to experience spike-related effects long after vaccination. They assert that vaccines were developed targeting the original Wuhan strain and may not cover Omicron; they suggest the shot’s risk-benefit balance is unfavorable given ongoing clotting, immune suppression, and cancer-inducing pathways, and they claim data indicate those who receive two or three shots may acquire Omicron at a higher rate than those unvaccinated. They conclude that the shot is expired for a virus that is no longer circulating in its original form and argue that vaccination induces dangerous pathologic processes with no protective benefit.

Research conducted by Bruce Patterson at InCelDx reveals that spike proteins can remain in the body for extended periods. In severe COVID cases, the s one segment was found in white blood cells for up to 15 months after infection. Even after vaccination, the full-length spike protein, including the s one and s two segments, was detected in white blood cells for at least 9 months. Another study from Stanford, led by Roelkern and colleagues, discovered messenger RNA, the genetic code for the spike protein, in lymph nodes for up to 2 months. These findings suggest that both messenger RNA and spike proteins can persist in the human body for several months.

it's modified mRNA, and it's designed not to degrade, and there are studies that show it sticks around the body. We don't know how long. The lipid nanoparticle was designed to permeate difficult to permeate barriers, like the blood brain, like placenta barrier. Did you believe when Fauci told us that the mRNA shot would stay in the arm? In rats, it biodistributed all over the body, accumulated in the adrenal glands, in the ovaries. This encapsulated lipid nanoparticle distributes all over the body, and when it attaches to a cell, it unloads its mRNA into the cell and turns the cell into a manufacturing cell of a protein that is toxic to it. They're turning cells like a heart cell into a manufacturing site for the spike protein, which is toxic, the body attacks it. The designers of the injection knew it. And Anthony Fauci knew it, and he lied. DNA contamination ... McKernan study ... 36 to 627 times. The allowed amount is ten nanograms per dose. That saves three point two million lives. No. It didn't. It's impossible. That's entirely possible.

Quan et al demonstrated that the introduction of DNA into a cell, even without integration, can trigger the oncogenic cGAS-STING pathway. The speaker claims that the presence of an SV40 origin of replication, a mammalian origin, in a vaccine grown in E. coli is reckless because it allows the plasmid DNA to replicate episomally in the host. The speaker alleges evidence suggests Pfizer, unlike Moderna, may have included this origin of replication due to carelessness. The speaker highlights concerns about nucleic acid persistence, noting that RT-PCR methods used in studies like Krausson and Rolchen may have amplified both DNA and RNA. The speaker suggests that prior studies assumed detected nucleic acids were RNA, but that further investigation using primers specific to the plasmid backbone might reveal the presence of residual plasmid DNA. The Krausson paper found nucleic acids present for thirty days in heart tissues, and the Rolchen paper found them for sixty days.

People tested at Quest have an upper antibody limit of 25,000. Unvaccinated individuals typically test under 1,000. Vaccinated individuals often test over 25,000, averaging ten times higher than the unvaccinated, even four years post-vaccination. These high antibody levels are alarming, suggesting persistent spike protein presence and potential health issues. COVID is no longer a major illness concern, but elevated antibody levels remain a concern.

To help cleanse the body of spike proteins from both the virus and the vaccine, a combination of nattokinase (2,000 to 4,000 units twice daily), bromelain (500 to 1,000 milligrams once daily), and curcumin (500 to 1,000 milligrams daily) is recommended. The spike protein, an engineered protein, may remain in the body for a long time and can lead to autoimmune responses, where the body attacks itself. Long COVID symptoms are attributed to the presence of this spike protein, which can persist after infection and is more abundant following vaccination. Antibodies against the spike protein can be measured, indicating its lingering presence in the body.

When mRNA vaccines are injected, the amount of protein produced is not directly controlled by the dose of RNA given. Factors like metabolism and cell activity influence protein output. Doses vary between Moderna and Pfizer vaccines, but the key is the spike protein produced in the body. Studies show some individuals may not produce enough spike protein for immunity, while others may have excess leading to side effects or toxicity. In vitro experiments may not accurately predict in vivo outcomes due to individual differences.

The vaccine's mRNA is identical to the RNA in our cells, which doesn't cause long-term adverse effects. The RNA in the vaccine is degraded within a week and completely gone. The lipid nanoparticles in the vaccine contain four types of fat, two of which are present in our cells and are gone within 24 to 48 hours. None of the vaccine's components remain in the body after days to a week. The mRNA doesn't integrate, affect, change, or mutate the DNA. Adverse events to vaccines mostly occur within the first six weeks, and with 15 million people already vaccinated, only rare anaphylaxis-like reactions have been observed. The chances of experiencing an unusual adverse event are less than 1 in 15 million.

For biodistribution, Pfizer did not use the actual spike mRNA product in their studies. Instead, they substituted in a luciferase reporter mRNA packaged in the same lipid nanoparticles. This approach allowed them to track where the mRNA traveled in rodents. The studies showed that following intramuscular injection, most of the mRNA remained at the site of injection, but there was also notable levels detected in the liver. Despite the limitations of this approach, which can underestimate low level or transient distributions to other tissues, it nevertheless showed that the vaccine components do not remain confined to the injection site. Next slide. For Moderna, no dedicated biodistribution study was performed with the COVID mRNA itself. Instead, data was provided from a surrogate product, a CMV mRNA, mRNA-sixteen 47, which used the same lipid nanoparticle formulation. In their rat study, after intramuscular injections, high levels of the mRNA were detected at the injection site, but also in multiple organs such as the draining lymph nodes, spleen, eye, and liver. Lower levels were also found across a wide range of tissues, including the heart, lungs, testes, and brain. Importantly, this study clearly showed that the mRNA can cross the blood brain barrier. Next slide. Consistent with what is seen in animal studies, the vaccine mRNA and its spike protein have been detected in humans across multiple tissues, including blood, lymph nodes, the heart, and even the brain. These findings make it clear that the mRNA does not remain confined to the injection site. Importantly, persistence has been documented well beyond the initial hours or days, lasting weeks in some tissues, and in certain studies detectable for many months. Next slide. To summarize the biodistribution data, it's important to note that neither Moderna nor Pfizer used their actual commercial mRNA vaccine products in the preclinical biodistribution studies. Instead, they relied on surrogate construct packaged in same or similar lipid nanoparticles. Second, the results of those studies show that the mRNA and lipid nanoparticles were not confined to the injection site. Systemic distribution was observed with evidence that the mRNA can cross the blood brain barrier. Consistent with these findings, studies in humans have confirmed that vaccine mRNA can be detected in multiple tissues, including lymph nodes, the heart, the central nervous system, and blood. Finally, persistence is not just short term. In some reports, mRNA has been detected for weeks to months, and in certain cases as long as seven zero six days post vaccination. Taken together, these data highlight that biodistribution is broad and persistence is longer than initially expected, raising important questions and concerns for ongoing research and safety monitoring.

Chakrabarty reviewed the Ryan et al and Odek studies, mapping reads to plasmids and finding significant spike sequence from RNA, and less from plasmid DNA, which is expected. RNA sequencing protocols suppress DNA, yet DNA is still present. The Odek study shows the entire vector backbone covered with sequencing reads, indicating heavy contamination and the presence of SV40 promoters in patients. This is evidenced across multiple studies. The Novel study had a lighter density of reads, but some plasmid DNA was detectable. The Lee et al study also showed some SV40 reads. These are more apparent in samples taken closer to vaccination, despite DNA suppression methods. A mice study on vaccine redentilation showed poly A tails regenerate, potentially lengthening RNA lifespan, but DNA contamination was also present.

Cette vidéo résume: selon Nakaoota et al. (3 avril 2025), « l’expression de la protéine Spike chez 43.8 pour 100 des personnes vaccinées anti Covid » persiste « au niveau des artères coronaires » jusqu’à 17 mois après l’injection, avec « l’ARN messager, du vaccin, mais également du virus » détecté. Il y a « persistance de la protéine Spike » et « persistance du SARS-CoV-2 » possiblement malgré les traitements précoces. L’auteure mentionne aussi « Crüssfeld Jacob, 14 mois après infection » et une étude sur des « AVC 17 mois après injections ». L’interaction de la nucléocapside (protéine N) avec TRIM28 pourrait retarder la réponse immunitaire innée, renforçant la tolérance immunitaire via TLR2/RAGE et IgG4. Conséquences: infection potentiellement asymptomatique et dégâts cumulatifs; Spike persistante pourrait entraîner « spike viral plus spike vaccinal ». Des spycopathies neurologiques sont évoquées; dépistage de Spike et traque du virus recommandés; traitements personnalisés et soutien par curcumine, quercétine, vitamine D; approche individuelle. This video summarizes: according to Nakaoota et al. (April 3, 2025), « the expression of the spike protein in 43.8 per 100 of vaccinated people » persists « at the level of the coronary arteries » for up to 17 months after injection, with « mRNA from the vaccine, but also the virus » detected. There is « persistence of the Spike protein » and « persistence of SARS-CoV-2 » possibly despite early treatments. The author also cites « Crüssfeld Jacob, 14 months after infection » and a study on « strokes 17 months after injections ». The interaction of the nucleocapsid protein (N) with TRIM28 could delay the innate antiviral response, reinforcing immune tolerance via TLR2/RAGE and IgG4. Consequences: potentially asymptomatic infection and cumulative damage; persistent Spike could lead to « spike viral plus spike vaccinal ». Neurological spycopathies are discussed; diagnostics to detect Spike and tracking the virus are recommended; therapies to block/remove Spike and personalized approaches, with supports like curcumin, quercetin, vitamin D.

Finished with a patient today. He is in research. We're using a lab in Germany. We have detectable Pfizer messenger RNA in his body now three point two years after the shots. For sure. So people who took these shots, they've got it at least long term now. And I've testified in the House last year and I said, I think we've got five to fifteen years of concern here. This is very long acting genetic material. And I think we should assume that all messenger RNA coming forward is going to be very long acting in the body and we need to be prepared for it.

Speaker 0 lays out a numerical comparison between vaccine versus infection to determine which creates more spike proteins, according to the source material. First, the infection scenario. The unit counted is the virion (one complete virus particle). At the peak of infection, the body could be fighting off somewhere between one to 100,000,000,000 virions. Each virion has spike proteins on its surface, counted as between twenty five and fifty spikes per virion. The calculation multiplies the range of virions by the spikes per virion, giving a peak infection spike protein load of two to 10,000,000,000,000 spike proteins. Next, the vaccination scenario. The math starts with modified messenger RNA (modRNA) molecules in a vaccine dose. A single vaccine dose contains somewhere between 14 to 42,000,000,000,000 modRNA molecules. Each of these trillions of modRNA molecules can produce multiple spike proteins, ranging from 10 to 1,000 each. When the numbers are multiplied, the source calculates a potential total of up to 100,000,000,000,000,000 spike proteins (up to 10^17, i.e., up to one hundred quadrillion). Speaker 0 then contrasts the two scenarios. In a side-by-side view, the initial particles are billions of virions versus trillions of modRNA molecules. The timing differs as well: a natural infection builds up over about a week, whereas the vaccine dose is delivered all at once, in just a few seconds. The final totals are two to 10,000,000,000,000 spikes from infection versus a potential of up to one hundred quadrillion from vaccination. Visually, this difference is stark, with the infection spike protein bar being far smaller than the vaccine spike protein bar, illustrating an order-of-magnitude difference. The discussion then moves to the distribution and persistence of spike proteins. The source describes the virus's spread as more localized or comparatively narrow, while vaccine components are said to travel throughout the entire body, with accumulation in areas including major organs like the heart and the brain, and the potential to cross barriers such as the blood-brain barrier and the placental barrier. Regarding duration, spike mRNA was reportedly detected in cerebral arteries after seventeen months, and some vaccinated individuals were reportedly still spike positive for up to sixteen hundred days. The source concludes, “Your spike load is orders of magnitude higher via injection.” Speaker 0 notes that the numbers show trillions versus quadrillions and emphasizes the presented math and its implications as the core of the comparison, while acknowledging the source’s look at spike proteins’ distribution and persistence.

There is no question that the inclusion of DNA was not an accident, and the 1/3 DNA, 2/3 RNA ratio was intentional. The long-term effects of both DNA and RNA are influencing the ability to fight cancer. The key question is what effect the DNA has on the cell nucleus, and how to differentiate its damage from that of mRNA. mRNA is connected to ACE 2 receptors and causes damage throughout the reproductive and cardio systems. mRNA creates a spike protein flag, which the immune system attacks, leading to organ damage. The presence of DNA makes the process last longer. While mRNA would create spike for 8-12 months, DNA can influence the nucleus for years, producing mRNA near the nucleus. This extends the process from months to 8-10 years due to the decision to include DNA.

A colon biopsy from a Pfizer-vaccinated individual who died a month after tumor emergence revealed SV40 in the origin of replication from the Pfizer vaccine. Preliminary sequencing suggests the presence of Pfizer's vaccine. The vaccine DNA copy number was greater than the human genome, indicating replication. PCR signals suggest the vaccine concentration is similar to or higher than the original vial, despite dilution in the body. This indicates the mammalian origin of replication in Pfizer's vaccine is active in human tumors. This finding may explain shedding, which is not supposed to occur because the COVID vaccine is not intended to alter DNA. However, evidence suggests that the vaccine may be altering DNA, making it a VGBT (genome altering) product. This could mean that spike proteins are continually created, and shedding is real.

The mRNA COVID-19 vaccine delivers instructions for creating spike proteins, which then trigger an immune response. The vaccine components are said to break down and disappear from the body within days, leaving no trace and unable to affect DNA. However, some claim that data from the Therapeutic Goods Administration in Australia shows the vaccine distributes throughout the body, not just the injection site, and that there was no data on how quickly it degrades. Research indicates vaccine mRNA can be detected in some individuals for up to 14-15 days. A rare post-vaccination syndrome (PVS) is described where individuals exhibit elevated levels of spike protein for extended periods, up to 709 days, along with reactivation of dormant viruses. A hypothesis suggests that in some individuals, the vaccine mRNA may reverse transcribe and integrate into DNA, causing continuous spike protein production and potentially leading to T-cell exhaustion. The concern is raised about the long-term health consequences and potential for germline transfer if DNA is altered.

Speaker 0 describes what he claims is the strongest case report ever done on vaccine injury, specifically mRNA vaccine injury. The subject is a 51-year-old man who developed myocarditis, pulmonary embolism, neurological disturbances, and skin disturbances, constituting multisystem long vaccine syndrome. The key findings are said to be detected 3.6 years after his last shot. Exosomes circulating in his body allegedly contain Pfizer mRNA, and this mRNA is still present in those exosomes years after vaccination. The same mRNA is reportedly also found in his skin. In addition, plasmid DNA from the manufacturing process is claimed to be present in his skin, again 3.6 years after vaccination. Specifically, the plasmid DNA allegedly includes the SV40 segment, the spike expression cassette, and the open reading frame region, with all components of the plasmids in the Grover's disease–affected skin area. Microscopic analysis of the Grover’s disease area allegedly showed staining for SARS-CoV-2 spike or vaccine spike, indicating the presence of spike protein in that skin region. This staining for spike protein is reported as occurring 3.6 years after the shot. Overall, the speaker asserts that all vaccine components—mRNA, plasmid DNA with defined segments, and spike protein—remain in the body for multiple years, with findings in exosomes and skin indicating long-lasting presence. The speaker also asserts that this represents a situation in which “we were completely lied to.”

Residual effects from one or two COVID shots can include late blood clots and cardiac arrests years later. The mRNA and spike protein from the shots can linger in the body, causing various health issues like heart and brain damage, blood clots, and immunologic problems. A spike detox program is recommended to address these concerns.

There's new evidence suggesting shedding might be real. The mRNA vaccines were called vaccines instead of gene therapy so they wouldn't have to test for shedding on non-injected people. We're giving your body the code to make the virus' spike protein, creating immunity. The spike protein alone won't kill you, but your body learns to eliminate it. If you later get COVID, your body will recognize and attack the spike protein. However, there's no guarantee your body stops producing the spike protein. Your cells, once healthy, now make spike proteins, which your immune system attacks, even if it's your own cells. The mRNA in the vaccines is stabilized to last longer and is coated in lipid nanoparticles to protect it and cross the blood-brain barrier.

Yale researchers discovered COVID spike proteins in the blood of individuals who received mRNA vaccines, even up to two years post-vaccination, without prior COVID infection. This raises concerns that the vaccine's genetic material may have integrated with human DNA, leading to ongoing spike protein production. While the findings suggest potential long-term effects, they do not definitively prove genetic integration. The researchers plan to publish their findings on a preprint server and seek validation from an independent lab. These developments could have significant implications for mRNA vaccine safety guidelines affecting over a billion vaccinated individuals. Further details will be shared as the research progresses.

The mRNA COVID-19 vaccine delivers instructions for creating spike proteins, which then triggers an immune response. The vaccine and spike protein are said to break down and disappear within days, leaving no trace and not affecting DNA. The vaccine is taken up at the injection site and quickly metabolized. However, an Australian Therapeutic Goods Administration document indicates the vaccine distributes throughout the body, including adipose tissue, adrenal glands, and the brain. There was allegedly no data on how quickly the mRNA degrades. Research indicates vaccine mRNA can be detected up to 14-15 days post-vaccination in some individuals. A rare post-vaccination syndrome (PVS) is associated with chronic conditions and elevated spike protein levels up to 709 days post-vaccination, even without detectable SARS-CoV-2 infection. One hypothesis suggests that the mRNA may reverse transcribe and integrate into DNA, causing continuous spike protein production and potentially leading to T cell exhaustion. The possibility of germline transfer and long-term health consequences is raised.

They examined tissues for spike and nucleocapsid proteins. Spike proteins are targeted by vaccines, while nucleocapsid proteins are not. In a patient positive for SARS-CoV-2, spike proteins were found in respiratory secretions, but nucleocapsid proteins were not. In an autopsy of a vaccinated patient who was not tested for SARS-CoV-2, spike proteins were present in the brain, but no nucleocapsid proteins were detected. The absence of nucleocapsid proteins in the brain is unexplained.

The mRNA COVID vaccine gives your body instructions to create copies of spike proteins. As soon as the spike protein is made, the vaccine breaks down and disappears from your body, usually within a matter of days or even hours. The vaccine is administered into your arm muscle, where it's quickly metabolized. The vaccine is taken up at the injection site and does not diffuse throughout the body. Your cells destroy the vaccine and recycle its components. Your immune system recognizes the spike proteins and learns how to fight the virus, without you actually getting sick. After a few days, all the mRNA from the vaccine is gone and the spike proteins that your cells produced are destroyed by your immune system. The only thing that remains is the memory of how to fight COVID-19, so your immune system is ready if it encounters the virus again. There is nothing to fear from the vaccine.

Pfizer did not use the actual spike mRNA; a luciferase reporter mRNA in the same lipid nanoparticles tracked biodistribution in rodents. After injection, most mRNA remained at the injection site, but notable levels were detected in the liver; limitations may underestimate low-level distributions, yet components are not confined to the injection site. Moderna did not perform a dedicated biodistribution study with the COVID mRNA; data came from a surrogate CMV mRNA (mRNA-sixteen 47) in the same lipid nanoparticle. In rats, high levels at the injection site and in draining lymph nodes, spleen, eye, and liver; lower levels in heart, lungs, testes, and brain, with the mRNA crossing the blood brain barrier. In humans, vaccine mRNA and its spike protein have been detected across blood, lymph nodes, heart, and brain, with persistence lasting weeks to months and reportedly seven zero six days post vaccination.